PRRI

The UN Convention on Biological Diversity’s (CBD) biosafety negotiations have been the target ofbiotech industry lobbyists and pro-biotech governments from the outset. But some have taken a more subtle approach to their lobbying, hiding their agenda beneath a veneer of public interest. Scrape beneath the surface however and their links to the biotech industry become clear. One such organisation is the Public Research and Regulation Initiative (PRRI) which appeared on the scene after the first biosafety negotiations under the CBD. Apparently independent from industry,this group claims to represent the “public research sector” – but how public is public research when GM is involved? Corporate Europe Observatory exposes PRRI as a corporate driven pro-biotech lobby group on biosafety issues

Subscribe to our newsletter

Follow us on social media

Some of the world’s biggest companies producing chemicals for agricultural use, such as Bayer and Monsanto, are gearing up to join forces through mergers. This article exposes how the European Commission has consolidated its pro-merger track record over the past decades.

Pressure has  been mounting on the European Central Bank over its purchases of certain corporate bonds, but new research shows no change. In its mission to stimulate the economy, it is still purchasing climate-harming bonds.

The European Food Safety Authority (EFSA) yesterday published its new independence policy. Unfortunately, EFSA's new policy generally seems to be holding on to the biggest loopholes from its previous rules. This limits the effectiveness of the improvements that have been made.

After many years of criticism and a very long drafting process, EFSA has finally adopted and published its new independence policy. But does it solve the problems it needs to solve? A lot remains unclear. Here is our first analysis.